Amylyx Pharmaceuticals, Inc. (AMLX)

CIK 1658551 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Amylyx Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 202610-Q0001193125-26-448529
Nov 5, 20268-K0001193125-26-448525
Oct 7, 202640001193125-26-416950
Oct 5, 20261440001950047-26-010033
Sep 14, 202640001193125-26-390506
Sep 14, 202640001193125-26-390509
Sep 14, 202640001193125-26-390508
Sep 14, 202640001193125-26-390507
Sep 14, 202640001193125-26-390510
Sep 11, 20261440001193125-26-389244
Sep 11, 20261440001193125-26-389246
Sep 11, 20261440001193125-26-389243
Sep 11, 20261440001193125-26-389245
Sep 11, 20261440001193125-26-389247
Sep 8, 20268-K0001193125-26-385331
Sep 2, 202640001193125-26-380152
Aug 20, 202640001193125-26-359678
Aug 20, 20268-K0001193125-26-359418
Aug 20, 202640001193125-26-359676
Aug 20, 202640001193125-26-359679
Aug 20, 2026424B50001193125-26-359416
Aug 20, 202640001193125-26-359677
Aug 20, 202640001193125-26-359675
Aug 18, 20268-K0001193125-26-354716
Aug 18, 20268-K0001193125-26-354793